Quarterly ResultApr 14, 2026, 12:48 PM
Biomerica Cash & Equivalents Drop to $1.34M in Q3 FY2026
AI Summary
Biomerica, Inc. filed its quarterly report (Form 10-Q) for the period ended February 28, 2026. The company's cash and cash equivalents significantly decreased to $1,336,000 as of February 28, 2026, down from $2,399,000 reported on May 31, 2025. This substantial reduction in liquidity over the nine-month period may raise concerns for investors.
Key Highlights
- Cash and cash equivalents fell to $1.34M by Feb 28, 2026.
- Cash was $2.40M as of May 31, 2025.
- 3,090,269 common shares outstanding as of April 13, 2026.
- Filed Form 10-Q for Q3 FY2026.